TOXOPLASMA GONDII INFECTION IN CANCER PATIENTS IN GUILAN
Publish place: 19th International Congress of Microbiology of Iran
Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 467
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
MEDISM19_443
تاریخ نمایه سازی: 13 مهر 1397
Abstract:
Background and Aim:Toxoplasma infection in immunocompromised individuals, such as individuals malignant patient under chemotherapy, can cause severe disease as encephalitis or systemic infections. This report is first study about prevalence of Toxoplasmosis in cancer patients in Guilan-North of Iran.Methods:This Case control study was performed on Cancer patients referred to Educational Hospital in Rasht (North of Iran), from July 2017 to January 2018. Blood samples were collected from 148 cancer patients having different types of malignancies would like to contribute in our study, as well as 150 immunocompetent individuals as a control group, to assess the seroprevalence of anti-T.gondii antibodies.Results:The antibodies (IgG/IgM) were measured by ELISA method. Overall, 71 cases were female and 79 cases were male. The results showed that one patients (1/148) (IgG+, IgM+) with acute phase, 94/148 (%) (IgG+, IgM-) chronic phase and 1/148 (%) (IgG-, IgM+) false positive.Conclusion:These data showed high percent of patients were susceptible to reactivation of latent toxoplasmosis. For this reason, it is important that patients with toxoplasmosis infection are diagnosed and identified in order to refer them for early therapy or other interventions.
Keywords:
Authors
Mohammad Reza Mahmoudianloo
Cellular and Molecular Research Center, Guilan University of Medical Sciences, Rasht- Iran
Ebrahim Rajabi
Faculty of medicine, Guilan University of Medical Sciences, Rasht- Iran
Farshid Saadat
Faculty of medicine, Guilan University of Medical Sciences, Rasht- Iran